Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

The hormonal contraceptive combination effectively reduces androgen excess and improves PCOS symptoms like acne, hair loss, and menstrual issues.

Targeting androgen receptors with antiandrogen oligonucleotides could effectively treat hair loss.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Estetrol (E4) can help hair grow longer by extending its growth phase.

Spironolactone may be a better acne treatment for adult women than antibiotics.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

The treatment slightly increased hair growth and was safe for most women.

Antiandrogens can treat excess body hair and hair loss by blocking male hormones.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Hormone therapy can improve sexual health and quality of life for women 70 and older.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.